Rallybio CorporationRLYBNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-3842.89%
↓ 102% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-1904.89%
Historical baseline
PeriodValueYoY Change
TTM-3842.89%+59.5%
2024-9491.35%-
20230.00%-
20220.00%-
20210.00%-
20200.00%-
20190.00%-